P909-1831 Screening compound: [3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl](6-methyl-3-pyridyl)methanone

P909-1831 Screening compound: [3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl](6-methyl-3-pyridyl)methanone
P909-1831 Screening compound: [3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl](6-methyl-3-pyridyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound P909-1831
[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl](6-methyl-3-pyridyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P909-1831

Molecular Formula

C16H18N4O2 (C16 H18 N4 O2)

Compound Name

[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl](6-methyl-3-pyridyl)methanone

IUPAC name

5-[3-(3-cyclopropyl-124-oxadiazol-5-yl)pyrrolidine-1-carbonyl]-2-methylpyridine

SMILES

Cc(cc1)ncc1C(N(CC1)CC1c1nc(C2CC2)no1)=O

InChI

InChI=1S/C16H18N4O2/c1-10-2-3-12(8-17-10)16(21)20-7-6-13(9-20)15-18-14(19-22-15)11-4-5-11/h2-3,8,11,13H,4-7,9H2,1H3/t13-/m1/s1

InChI Key

CLMKAACWDKBOID-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD29033270

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

298.34

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.151

Distribution Coefficient, logD

2.151

Water Solubility, LogSw

-2.22

Polar Surface Area

58.059

Acid Dissociation Constant (pKa)

24.36

Base Dissociation Constant (pKb)

4.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

P909-1831 in Drug Discovery

Included in Screening Libraries

3D-Fragment Library (4274 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with P909-1831 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P909-1831?
Check Price and Availability of P909-1831, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P909-1831 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P909-1831
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P909-1831
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P909-1831 available by request